LL-37 is the sole human cathelicidin antimicrobial peptide (37 residues, amphipathic α-helix), investigated extensively in innate immunity, bacterial biofilm disruption, LPS neutralization, and wound re-epithelialization.
Scientific Profile & Research Key Points: LL-37
LL-37 is the sole human cathelicidin antimicrobial peptide (37 residues, amphipathic α-helix), investigated extensively in innate immunity, bacterial biofilm disruption, LPS neutralization, and wound re-epithelialization.
Active Batch Release Specifications (Lot SL-2026-142)
Analytical release verification for current LL-37 (5 mg) inventory
| Batch Lot # | Release Date | Analytical Method | Purity Spec | Endotoxin (LAL) | Moisture |
|---|---|---|---|---|---|
| SL-2026-142 | 2026-10-28 | RP-HPLC (C18, 214nm) + ESI-MS | ≥99.0% (Single Peak) | <0.5 EU/mg | <2.8% (Karl Fischer) |
Laboratory Solubilization & Storage Protocol
Recommended Solvent / Handling
Sterile water or 0.9% Bacteriostatic Water; avoid high-salt precipitation at concentrated stocks
Temperature & Stability
Store lyophilized at -20°C; refrigerate reconstituted solution at 2°C–8°C for up to 21 days.
LL-37 — Technical Questions & Answers
What is the molar concentration when reconstituting LL-37 (5 mg) in 2.0 mL?
Reconstituting the full 5 mg vial of LL-37 (MW 4493.26 g/mol) in 2.0 mL of diluent produces a 2.50 mg/mL stock solution — equivalent to approximately 0.56 mM (556 µM) gross molarity before Net Peptide Content (NPC) adjustment.
How does LL-37's counterion stoichiometry affect assay mass calculations?
LL-37 (CAS 154947-66-7, formula C205H340N60O53) is supplied as Acetate lyophilized salt. Because counterions and residual bound water contribute to gross lyophilized weight, quantitative receptor-binding assays should apply batch Net Peptide Content (NPC) or active-ion correction rather than gross cake weight alone.
Which analytical methods verify LL-37 Lot SL-2026-142 and what pathway does it target?
Lot SL-2026-142 undergoes RP-HPLC (C18, 214nm) + ESI-MS confirming ≥99.0% (Single Peak) and identity against 4493.26 g/mol. In preclinical literature, LL-37 targets Antimicrobial membrane disruption, FPR2 chemotaxis & biofilm inhibition (Dürr U.H.N. et al., Biochim Biophys Acta (2006) — LL-37 structure and host-defense antimicrobial activity (PMID: 16759636)).
Related Scientific Monographs
Peer-reviewed mechanism summaries and analytical protocols
How to Read a Peptide Certificate of Analysis (COA): Step-by-Step Breakdown
A practical guide for researchers. How to analyze HPLC chromatograms, verify retention time, interpret mass spec m/z peaks, evaluate counterion salt ratios, and spot fraudulent documents.
How to Reconstitute Research Peptides: Complete Laboratory Protocol and Best Practices
Standard Operating Procedure (SOP) for peptide reconstitution. Diluent selection (BAC water vs acetic acid), meniscus calculations, avoiding foaming, and cold storage parameters.
Peptide Storage and Stability: A Comprehensive Laboratory Guide
Analytical protocols for preserving lyophilized and reconstituted peptides. Temperature zones (-80°C, -20°C, 4°C), freeze-thaw degradation, hygroscopicity, and photostability.
Related Recovery & Tissue Repair Compounds
View category →